Newsroom

Filtrer par
TRB Chemedica International S.A. and InnoMedica Holding AG enter in a long-term relationship regarding the production of GM1 (monosialotetrahexosylganglioside) and its development as a liposomal formulation under the trade name Talineuren®

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

Learn More
TRB Chemedica International is one of the proud sponsors of the conference L’homme cérébral

Scientific conference “L’homme cérébral”, 30 March 2019, Monaco
 

Learn More
World Congress 2019 on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, TRB Chemedica

World Congress 2019 on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Learn More

Football medicine meets the universe of sport at the Isokinetic Medical Group Conference

Learn More
european-business-trb-chemedica-interview

Read the European Business magazine interviews of Alessandro di Napoli

Learn More
Danny Webber football and Sports medecin with TRB Chemedica

Hyaluronic acid injections help to prolong sports careers for football players

Learn More